REFRACTORY MYELODYSPLASTIC CHRONIC MYELOMONOCYTIC LEUKEMIA

Clinical trials for REFRACTORY MYELODYSPLASTIC CHRONIC MYELOMONOCYTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY MYELODYSPLASTIC CHRONIC MYELOMONOCYTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY MYELODYSPLASTIC CHRONIC MYELOMONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for older leukemia patients: targeted radiation before transplant may reduce side effects

Disease control Not yet recruiting

This study tests a new way to prepare older patients (50 and older) with leukemia or MDS that has not responded to treatment for a stem cell transplant. Instead of full-body radiation, they receive targeted radiation to the bone marrow and lymph nodes, plus two chemotherapy drugs…

Matched conditions: REFRACTORY MYELODYSPLASTIC CHRONIC MYELOMONOCYTIC LEUKEMIA

Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated May 17, 2026 05:07 UTC

REFRACTORY MYELODYSPLASTIC CHRONIC MYELOMONOCYTIC LEUKEMIA

Get alerted when new REFRACTORY MYELODYSPLASTIC CHRONIC MYELOMONOCYTIC LEUKEMIA trials appear

New hope for older leukemia patients: targeted radiation before transplant may reduce side effects